日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Revumenib 抑制 Menin 治疗 KMT2A 重排复发或难治性急性白血病 (AUGMENT-101)

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究

Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

对60岁及以上新诊断急性髓系白血病患者进行分子特征分析:来自Beat AML临床试验的报告

Hoff, Fieke W; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Patel, Prapti A; Collins, Robert H Jr; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F

TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL

TP53 突变与 CD19 阴性复发以及成人急性淋巴细胞白血病 (ALL) 患者接受 blinatumomab 治疗后预后不良相关。

Aldoss, Ibrahim; Li, Shanpeng; Zhang, Jianying; Clark, Mary C; Agrawal, Vaibhav; Pourhassan, Hoda; Koller, Paul; Aribi, Ahmed; Ali, Haris; Blackmon, Amanda; Otoukesh, Salman; Sandhu, Karamjeet; Ball, Brian; Arslan, Shukaib; Artz, Andrew; Amanam, Idoroenyi; Al Malki, Monzr M; Salhotra, Amandeep; Kovacsovics, Tibor; Murphy, Lindsey; Afkhami, Michelle; Ngo, Dat; Tinajero, Jose; Gu, Zhaohui; Becker, Pamela S; Nakamura, Ryotaro; Stein, Anthony; Marcucci, Guido; Forman, Stephen J; Pullarkat, Vinod

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

一项针对 60 岁及以上未经治疗的急性髓系白血病患者,评估 TP-0903 和地西他滨靶向突变型 TP53 和/或复杂核型的 1b/2 期研究

Eisenmann, Eric D; Swords, Ronan; Huang, Ying; Orwick, Shelley; Buelow, Daelynn; Abbott, Nicole; Phelps, Mitch; Zeidner, Joshua; Foster, Matthew C; Lin, Tara L; Baer, Maria R; Madanat, Yazan F; Kovacsovics, Tibor; Redner, Robert; Al-Mansour, Zeina; Bhatnagar, Bhavana; Stefanos, Mona; Martycz, Molly; Druggan, Franchesca; Chen, Timothy L; Yocum, Ashley O; Borate, Uma; Druker, Brian J; Burd, Amy; Levine, Ross L; Byrd, John C; Baker, Sharyn D; Mims, Alice S

Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS-R Scores at Academic Cancer Centers

学术癌症中心根据IPSS-R评分对骨髓增生异常综合征(MDS)患者治疗模式和预后的影响

Willis, Connor; Hejazi, Andre; Williams, Vonetta L; Comperatore, Craig; Tantravahi, Srinivas; Ali, Najla Al; Gilreath, Jeffrey; Kovacsovics, Tibor; Au, Trang; Tan, Malinda; Brendle, Madeline; Komrokji, Rami; Yoo, Minkyoung; Ashraf, Mushtaq; Khakwani, Aamir; Iorga, Şerban R; Sadek, Islam; Sallman, David A; Stenehjem, David

Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Beat-AML 2024 ELN 针对接受低强度治疗的新诊断 AML 老年患者进行了风险分层优化

Hoff, Fieke W; Blum, William G; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Archer, Kellie J; Patel, Prapti A; Collins, Robert H; Baer, Maria R; Duong, Vu H; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F

A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents

一项多中心 Ib 期临床试验,旨在评估组蛋白去乙酰化酶抑制剂恩替诺特联合帕博利珠单抗治疗对低甲基化药物耐药的骨髓增生异常综合征/肿瘤或急性髓系白血病患者的疗效。

Bewersdorf, Jan Philipp; Shallis, Rory M; Sharon, Elad; Park, Silvia; Ramaswamy, Rahul; Roe, Caroline E; Irish, Jonathan M; Caldwell, Anne; Wei, Wei; Yacoub, Abdulraheem; Madanat, Yazan F; Zeidner, Joshua F; Altman, Jessica K; Odenike, Olatoyosi; Yerrabothala, Swaroopa; Kovacsovics, Tibor; Podoltsev, Nikolai A; Halene, Stephanie; Little, Richard F; Piekarz, Richard; Gore, Steven D; Kim, Tae Kon; Zeidan, Amer M

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia

米哚妥林联合伊达比星和阿糖胞苷诱导治疗FLT3突变型急性髓系白血病的疗效和毒性

Lee, Julia S; Wagner, Charlotte B; Prelewicz, Stacy; Kurish, Heena P; Walchack, Robert; Cenin, Danielle A; Patel, Seema; Lo, Mimi; Schlafer, Danielle; Li, Belinda K T; Donald Harvey Iii, R; Wasef, Bestis; Ying, Jian; Kovacsovics, Tibor

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

培沃地司他联合阿扎胞苷治疗TP53突变型急性髓系白血病老年患者:一项包含实验室相关性的II期研究

Saliba, Antoine N; Kaufmann, Scott H; Stein, Eytan M; Patel, Prapti A; Baer, Maria R; Stock, Wendy; Deininger, Michael; Blum, William; Schiller, Gary J; Olin, Rebecca L; Litzow, Mark R; Lin, Tara L; Ball, Brian J; Boyiadzis, Michael M; Traer, Elie; Odenike, Olatoyosi; Arellano, Martha L; Walker, Alison; Duong, Vu H; Kovacsovics, Tibor; Collins, Robert H; Shoben, Abigail B; Heerema, Nyla A; Foster, Matthew C; Peterson, Kevin L; Schneider, Paula A; Martycz, Molly; Gana, Theophilus J; Rosenberg, Leonard; Marcus, Sonja; Yocum, Ashley O; Chen, Timothy; Stefanos, Mona; Mims, Alice S; Borate, Uma; Burd, Amy; Druker, Brian J; Levine, Ross L; Byrd, John C; Foran, James M